![](/img/cover-not-exists.png)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Paul, Mical, Daikos, George L, Durante-Mangoni, Emanuele, Yahav, Dafna, Carmeli, Yehuda, Benattar, Yael Dishon, Skiada, Anna, Andini, Roberto, Eliakim-Raz, Noa, Nutman, Amir, Zusman, Oren, Antoniadou,Language:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(18)30099-9
Date:
February, 2018
File:
PDF, 303 KB
english, 2018